Applied relaxation and oral estradiol treatment of vasomotor symptoms in postmenopausal women

Maturitas

Volumn 51, Issue 2, 2005, Pages 154-162

  Nedstrand, Elizabeth ^a   Wijma, Klaas ^a   Wyon, Yvonne ^a   Hammar, Mats ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alternative treatments; Applied relaxation; Hot flushes; Menopause

Indexed keywords

ESTRADIOL; GESTAGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HOT FLUSH; HUMAN; INTERMETHOD COMPARISON; MENOPAUSAL SYNDROME; MOOD; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RELAXATION TRAINING; TREATMENT OUTCOME; VASOMOTOR DISORDER; VASOMOTOR REFLEX; VISUAL ANALOG SCALE; WELLBEING;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ESTRADIOL; FEMALE; FOLLOW-UP STUDIES; HOT FLASHES; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; RELAXATION TECHNIQUES; TREATMENT OUTCOME;

EID: 19444371165     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2004.05.017     Document Type: Article

References (35)

1. S.M. McKinlay, D.J. Brambilla, and J.G. Posner The normal menopause transition Maturitas 14 1992 103 115
2. G.A. Greendale, N.P. Lee, and E.R. Arriola The menopause Lancet 353 1999 571 580
3. E. Stadberg, L.Å. Mattsson, and I. Milsom Factors influencing the prevalence and severity of climacteric symptoms and the use of hormone replacement therapy Acta Obstet Gynecol Scand. 79 2000 286 292
4. L. Thunell, E. Stadberg, L.Å. Mattsson, and I. Milsom Treatment of climacteric symptoms-a longitudinal study Maturitas 35 Suppl. I 2000 51
5. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. J Am Med Assoc 2002;288:321-33.
6. D.M. Herrington, E. Vittinghoff, F. Lin for the HERS Study Group Statin therapy, cardiovascular events and total mortality in the heart estrogen/progestin replacement study (HERS) Circulation 105 2002 2926 2927
7. E. Stadberg, L.Å Mattsson, and I. Milsom Women's attitude and knowledge about the climacteric period and its treatment. A Swedish based population Maturitas 27 1997 109 116
8. C. Magnusson, J.A. Baron, N. Correia, A. Ekbom, R. Bergström, and H.O. Adami Breast cancer risk following long-term oestrogen- and progestin-replacement therapy Int. J. Cancer 81 1999 339 344
9. The Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the million women study. Lancet 2003;362:419-27.
10. S.L. Wardlaw, W.B. Wehrenberg, M. Ferin, J.L. Antunes, and A.G. Frantz Effect of sex steroids on β-endorphin in hypophyseal portal blood J. Clin. Endocrinol. Metab. 55 1982 877 881
11. J.F. D'Amico, G.A. Greendale, J.K. Lu, and H.L. Judd Induction of hypothalamic opioid activity with transdermal estradiol administration in postmenopausal women Fertil. Steril. 55 1991 754 758
12. R.R. Freedman, S. Woodward, B. Brown, I.J. Javaid, and G.N. Pandey Biochemical and thermoregulatory effects of behavioral treatment for menopausal hot flushes Menopause 4 1995 211 218
13. D. Shoupe, and R. Lobo Endogenous opioids in the menopause L. Speroff R. Lobo Role of opioid peptides in reproductive endocrinology. Seminars in reproductive endocrinology, vol. 5, no. 2 1987 Thieme Medical Publishers Inc. New York 199 206
14. D. Lee, S. Kimura, V. De Quattro, and G. Davison Relaxation therapy lowers blood pressure in hypertensives with raised plasma norepinephrine and blunts pressor response to anger Clin. Exp. Hyperten. Part A, Theor. Pract. 11 Suppl. 1 1989 191 198
15. J.W. Hoffman, H. Benson, and P.A. Arns Reduced sympathetic nervous system responsivity associated with the relaxation response Science 215 1981 190 192
16. P. Hjemdahl, J. Fagius, and U. Freyschusss Muscle sympathetic activity and norepinephrine release during mental challenge in humans Am J Physiol. 257 1989 341 347
17. L.G. Öst Applied relaxation: description of a coping technique and review of controlled studies Behav. Res. Ther. 25 1987 397 409
18. K. Wijma, A. Melin, E. Nedstrand, and M. Hammar Treatment of menopausal symptoms with applied relaxation: a pilot study J. Behav. Ther. Exp. Psychiatry 28 1997 251 264
19. R.R. Freedman, and S. Woodward Behavioral treatment of menopausal hot flushes: evaluation by ambulatory monitoring Am. J. Obstet. Gynecol. 167 1992 436 439
20. M. Hunter, and K.L.M. Liao Evaluation of a four session cognitive-behavioural intervention for menopausal hot flushes Br. J. Health Psychol. 1 1996 113 125
21. Wyon Y, Wijma K, Nedstrand E, Sandberg M, Hammar M. A comparison of acupuncture and oral estradiol treatment of vasomotor symptoms in postmenopausal women. Climacteric, in press.
22. Lindh-Åstrand L, Nedstrand E, Wyon Y, Hammar M. The effects of physical activity and estrogens on vasomotor symptoms and quality of life in postmenopausal women. Maturitas 2004;48:97-105.
23. H.S. Kupperman, B.B. Wetchler, and M. Blatt Contemporary therapy of the menopausal syndrome J. Am. Med. Assoc. 171 1959 103 113
24. Y. Wyon, R. Lindgren, T. Lundeberg, and M. Hammar Effects of acupuncture on climacteric vasomotor symptoms, quality of life and urinary excretion of neuropeptides among postmenopausal women Menopause 2 1995 3 12
25. L.R. Derogatis, R.S. Lipman, and L. Covi SCL-90: an outpatient psychiatric rating scale-preliminary report Psychopharm Bull. 9 1973 13 27
26. L. Sjöberg, E. Svensson, and L.-O. Persson The measurement of mood Scand. J. Psychol. 20 1979 1 18
27. E. Alder The Blatt-Kupperman menopausal index: a critique Maturitas 20 1998 19 24
28. F.J. Cohen, and Y. Lu Characterization of hot flashes reported by healthy postmenopausal women receiving raloxifene or placebo during osteoporosis prevention trials Maturitas 34 2000 65 73
29. M. Amanzio, and F. Benedetti Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems J. Neurosci. 19 1999 484 494
30. F. Benedetti, C. Arduino, and M. Amanzio Somatotopic activation of opioid systems by target-directed expectations of analgesia J Neurosci. 19 1999 3639 3648
31. G. Ter Riet, A. de Craen, A. de Boer, and A. Kessels Is placebo analgesia mediated by endogenous opioids? A systemic review Pain 76 1998 273 275
32. J.D. Levine, N.C. Gordon, and H.L. Fields The mechanism of placebo analgesia Lancet 2 1978 654 657
33. MacLennan A, Lester S, Moore V. Oral estrogen replacement therapy versus placebo for hot flushes (Cochrane Review). In: The Cochrane Library, issue 2, 2001, Oxford: update Software.
34. C.L. Loprinzi, J.W. Kugler, and J.A. Sloan Venlaxafine in management of hot flushes in survivors of breast cancer: a randomized controlled trial Lancet 356 2000 2059 2063
35. C.L. Loprinzi, J.A. Sloan, and E.A. [et al.] Perez Phase III evaluation of fluoxetin for treatment of hot flashes J. Clin. Oncol. 20 2002 1578 1583